Skin cancer, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma, can cause serious health problems if not treated or if treatment is delayed. Medical practice administrators, owners, and IT managers need to understand how appointment delays affect patients and consider ways to improve scheduling. Delays not only hurt patient outcomes but also increase costs and use more health system resources.
This article looks at how long patients wait for dermatology appointments, how these delays affect skin cancer results, and how artificial intelligence (AI) and automation can help healthcare systems provide faster care.
Recent studies show how long people wait to see dermatologists in the U.S., especially in cities like New York City. One study found the average wait for hospital-associated dermatology visits in New York City was 50 days, while the median wait was just under 20 days. This means some patients wait a very long time. About 25% waited more than 60 days.
Insurance plays a big role in these delays. Medicaid patients waited around 30.5 days on average, more than twice the 13 days seen for patients with private insurance. About two-thirds of dermatologists accepted private insurance, Medicare, and Medicaid, but many only accepted private insurance or no insurance at all. This causes unequal access, especially for people from lower-income groups.
Only 56% of dermatologists offered online booking, and phone wait times averaged one minute but could be as long as seven minutes. These issues make it harder for patients to get quick appointments.
Skin cancer is the most common cancer in the U.S. Early detection and treatment usually lead to better health and fewer complications. Each type of skin cancer behaves differently, but delays can make risks higher for all patients.
Melanoma is the most dangerous form. Waiting more than six weeks for surgery after diagnosis is common, especially among Medicaid patients and nonwhite patients. These delays increase the chance the cancer will spread to places like lymph nodes, lungs, liver, or brain. This makes treatment harder and less likely to succeed.
Basal cell carcinoma grows slowly and rarely spreads, but delays let it hurt nearby tissue. If left untreated, it can cause damage, scarring, and loss of function. Quick treatment cures over 95% of cases, often with simple surgeries. Late treatment can lead to bigger surgeries and more costs.
Squamous cell carcinoma must also be treated quickly because it can spread. Early treatment is easier and less stressful than waiting, which can lead to more serious surgeries and emotional strain.
Delays or no treatment raise health risks and make care more difficult and costly. Advanced treatments like immunotherapy for melanoma are expensive and work less well than early care.
These factors combine to cause unequal care. People in vulnerable groups may get diagnosed late, have more advanced disease, and higher death rates.
Dermatology practices in the U.S. are using AI and workflow automation to reduce delays and help patients. For example, Simbo AI works on phone automation and AI answering systems to improve scheduling in clinics and hospitals.
Simbo AI’s phone automation helps busy clinics handle many calls without losing patients or keeping them waiting too long. This works well in cities like New York where demand for dermatology is high.
People who manage medical offices and IT must support changes that lower wait times and improve care. Since wait times vary a lot and insurance can cause delays, they should consider:
Cutting down appointment delays helps find and treat skin cancer early, which improves patient survival and quality of life. Early care can stop cancer from spreading, lower surgery risks, and save appearance and function.
Health systems save money by avoiding expensive late-stage treatments, emergency care, and lengthy follow-ups. Patients also feel less anxiety when diagnosis and treatment happen sooner.
Using AI and automation helps dermatology clinics serve more patients quickly, lowers differences in care access, and makes clinics work better overall.
The mean waiting time for an appointment was 50 days, while the median waiting time was 19.5 days, indicating significant variability in access across providers.
Providers accepting Medicaid had a median wait time of 30.5 days, compared to 13.0 days for those who did not accept Medicaid, highlighting disparities in access based on insurance coverage.
56% of dermatologists in NYC allowed appointments to be booked online, which may enhance access for patients seeking care.
Individuals of lower socioeconomic status face greater difficulties in scheduling appointments, as many dermatologists do not accept Medicaid, leading to increased disparities in access.
This study’s findings suggest that wait times may be considerably longer outside of NYC, where the density of specialists is lower.
Emerging tele-dermatology technologies can facilitate earlier evaluations and screenings, potentially mitigating access delays and improving timely care.
The study entailed calling the offices of dermatologists listed on hospital websites to inquire about appointment availability, insurance types, and hold times.
Outdated information on medical office websites about physician appointments may mislead patients and create additional barriers to accessing care.
Delays in treatment for skin conditions, particularly melanoma, can lead to worse outcomes and increased mortality risk, emphasizing the need for timely access.
The study underscores the need for new strategies, potentially involving AI and telehealth, to enhance treatment availability and reduce healthcare inequalities.